Gujarat Inject (Kerala) Ltd - Stock Valuation and Financial Performance

BSE: 524238 | NSE: | Pharmaceuticals & Drugs | Small Cap

Guj. Inject (Kerala) Share Price

15.69 0.54 3.56%
as on 26-Apr'24 16:01

DeciZen - make an informed investing decision on Guj. Inject (Kerala)

M-Cap below 100cr DeciZen not available

Gujarat Inject (Kerala) stock performance -

mw4me loader
P/E Ratio (SA):
469.07
Market Cap:
23 Cr.
52-wk low:
6.3
52-wk high:
15.8

Is Gujarat Inject (Kerala) Ltd an attractive stock to invest in?

1. Is Gujarat Inject (Kerala) Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Gujarat Inject (Kerala) Ltd is a below average quality company.

2. Is Gujarat Inject (Kerala) Ltd undervalued or overvalued?

The key valuation ratios of Gujarat Inject (Kerala) Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Gujarat Inject (Kerala) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gujarat Inject (Kerala) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Guj. Inject (Kerala):

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gujarat Inject (Kerala) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 1.6%1.6%-350.3%-3.3%9.2%2.8%-0.1%56.1%-1.3%-160.1%-
Value Creation
Index
NANA-26.0-1.2NANA-1.0NA-1.1-12.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0001.6000000.20
Sales YoY Gr.-NANA7,750%-100%NANANA100%750%-
Adj EPS -0-01.40-0-00-0.200.10
YoY Gr.-NANA-99.3%-400%NANANANANA-
BVPS (₹) -6.3-6.3-1.6-1.5-1.6-1.6-1.6-1.8-1.8-1.76.1
Adj Net
Profit
000.70000-0.1000
Cash Flow from Ops. 0000000-0.100.1-
Debt/CF from Ops. 0-3326.1-1797.7-555.5-56.4415.12678.1-6.5-741.517.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA750%
Adj EPS NANANANA
BVPSNANANANA
Share Price - - - 114.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
0.10.1-36.2-0.82.20.7-012.7-0.3-4.81.4
Op. Profit
Mgn %
004.10.6000-982.2-200.2-2171.2
Net Profit
Mgn %
004159.90.4000-911.29.823.611.9
Debt to
Equity
-0.8-0.9-0.7-0.8-0.8-0.8-0.8-0.8-0.8-1.1-
Working Cap
Days
003,153160001195113120
Cash Conv.
Cycle
00-6,395-20000489690

Recent Performance Summary

Sales growth is good in last 4 quarters at 73.75%

Return on Equity has declined versus last 3 years average to 1.40%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Gujarat Inject (Kerala) Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0.4 -
BVPS (₹.) 6.1 -
Reserves (₹ Cr.) -6 -
P/BV 2.56 -
PE 469.07 -
From the Market
52 Week Low / High (₹) 6.32 / 15.76
All Time Low / High (₹) 0.75 / 50.00
Market Cap (₹ Cr.) 23
Equity (₹ Cr.) 14.7
Face Value (₹) 10
Industry PE 48.8

Management X-Ray of Guj. Inject (Kerala):

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Guj. Inject (Kerala)

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales000.021.570000.010.020.17
Operating Expenses 000.021.560.070.020.010.120.070.55
Manufacturing Costs0000.01000000
Material Costs0001.510000.010.020.15
Employee Cost 000.010.010.020.01000.010.03
Other Costs 000.010.030.050.0100.110.040.37
Operating Profit 0000.01-0.07-0.02-0.01-0.11-0.05-0.38
Operating Profit Margin (%) --4.1%0.6%----982.0%-200.0%-217.0%
Other Income 00000.050.020.010.010.050.43
Interest 0000000000
Depreciation 0000000000
Exceptional Items 002.300000000
Profit Before Tax 002.300.01-0.02-0.010-0.1100.06
Tax 0000000000.01
Profit After Tax 002.300.01-0.02-0.010-0.1100.04
PAT Margin (%) --13,860.5%0.4%----911.0%9.8%23.6%
Adjusted EPS (₹)0.00.04.70.00.00.00.0-0.20.00.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund -3.06-3.06-0.76-0.75-0.77-0.78-0.78-0.88-0.88-0.84
Share Capital 4.884.884.884.884.884.884.884.884.884.88
Reserves -7.95-7.95-5.64-5.64-5.66-5.66-5.66-5.77-5.76-5.72
Minority Interest0000000000
Debt2.552.870.560.570.590.590.590.690.730.93
Long Term Debt00.310.310.310.310.310.310.420.420.42
Short Term Debt2.552.550.250.250.280.280.280.280.320.52
Trade Payables0.170.170.170000000
Others Liabilities 0.520.200.200.200.200.200.200.210.210.21
Total Liabilities 0.190.170.170.010.020.010.010.020.060.30

Fixed Assets

Gross Block0000000000
Accumulated Depreciation0000000000
Net Fixed Assets0000000000
CWIP 0000000000
Investments 0000000000
Inventories000000000.010
Trade Receivables0000000000
Cash Equivalents 0.020.020.020.020.010.010.010.010.010.06
Others Assets0.160.140.14-0.010.010000.050.24
Total Assets 0.190.170.170.010.020.010.010.020.060.30

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0000-0.0100-0.1100.05
PBT 0000.01-0.02-0.010-0.1100.06
Adjustment 0000000000
Changes in Working Capital 00-2.3-0.010.010.010-0-00.01
Tax Paid 000000000-0.01
Cash Flow From Investing Activity 0000000000
Capex 0000000000
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 00000000.1000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 00000000.1000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow 0000-0.0100000.05
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
ROCE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Asset Turnover Ratio000.117.360000.730.550.94
PAT to CFO Conversion(x)N/AN/A00N/AN/AN/AN/AN/A1.25
Working Capital Days
Receivable Days0000000000
Inventory Days000000097960
Payable Days0000000000

Gujarat Inject (Kerala) Ltd Stock News

Gujarat Inject (Kerala) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Guj. Inject (Kerala) on 26-Apr-2024 16:01 is ₹15.69.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 26-Apr-2024 16:01 the market cap of Guj. Inject (Kerala) stood at ₹22.98.
The latest P/E ratio of Guj. Inject (Kerala) as of 26-Apr-2024 16:01 is 469.1.
The latest P/B ratio of Guj. Inject (Kerala) as of 26-Apr-2024 16:01 is 2.56.
The 52-week high of Guj. Inject (Kerala) is ₹15.76 and the 52-week low is ₹6.32.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Guj. Inject (Kerala) is ₹0.37 ( Cr.) .

About Gujarat Inject (Kerala) Ltd

Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala.

The company was established  to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation, intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/ instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits.

Read More Read Less
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.